A RSK kinase inhibitor reporting its selectivity in vivo.
Frödin
Morten
M
D015195:Drug Design; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology*; D010293:Pargyline / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000494:pharmacology; D011437:Propylamines / Q000138:chemical synthesis / Q000494:pharmacology; D019893:Ribosomal Protein S6 Kinases / Q000037:antagonists & inhibitors*; D013379:Substrate Specificity
D004791:Enzyme Inhibitors; D011437:Propylamines; C009054:propargylamine; D010293:Pargyline; D019893:Ribosomal Protein S6 Kinases